Delphi Consensus on Clinical Management of WAS has been launched
Research, Education and Family support for WAS families worldwide
You CAN make a difference. Find out how you can help us in the fight against Wiskott-Aldrich Syndrome.
Ask our community of doctors and families your questions, or answer questions with your own experience and expertise.
Search emerging treatments for WAS such as Gene Therapy, learn about the criteria for eligibility, and find out how to apply.
Delphi Consensus on the clinical Management of Wiskott-Aldrich Syndrome for patients living with WAS has been launched.
You can now donate using Paypal
Please view Michael Albert, M.D Talk on "Time to stop using XLT and mild-WAS to label patients" on May 10, 2024 . Read the Q&A Report based on audience questions.
EL-PFDD Voice of the Patient report approved. Read the report here.
EL-PFDD Meeting Feb 3, 2023 event successful broadcast with participation of Physicians, Researchers, FDA WAS families and board members.
Wiskott-Aldrich Foundation Chairman Mike Skrynecki receiving notices for philanthropy award:
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease. Approval of these innovative gene therapies spells hope for approval of gene therapies for WAS.
Synthetic Platelets built to treat bleeding: A significant milestone in the field of bio-mimetic materials.
Deficiency of WASp in B cells leads to abnormalities in B cell function: A study using mice with isolated WASp deficiency in B cells.
To hear about some of our families, please see EL-PFDD broadcast.